Literature DB >> 15075745

Cardiac transplantation: the alternate list and expansion of the donor pool.

Jignesh Patel1, Jon A Kobashigawa.   

Abstract

PURPOSE OF REVIEW: Advances in immunosuppression and surgical techniques have allowed cardiac transplantation to become a viable option and the treatment of choice for select patients with end-stage heart failure. The success of the procedure has, however, led to a discrepancy between the number of donors available and the number of patients awaiting cardiac transplantation. As wait times for heart transplant recipients increase, nonstandard donor hearts are increasingly being used for higher risk recipients and critically ill (Status I) patients. We review the development of two recipient lists as a way to provide cardiac transplantation as an option to recipients who would be otherwise ineligible, and determine its impact on expanding the donor pool. Other methods of expanding the donor pool are also reviewed. RECENT
FINDINGS: The alternate list appears to be successful in offering transplantation to patients (mostly older patients) who would not normally be eligible for this life-saving procedure. The alternate list (by changing donor organ acceptance criteria) and ongoing programs to increase organ donation have helped to expand the donor pool.
SUMMARY: The donor organ shortage will continue as an increasingly older population develops end-stage organ disease. Expanding the donor pool by a variety of methods will be essential to extend the lives of these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15075745     DOI: 10.1097/00001573-200403000-00017

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

1.  Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation.

Authors:  Todd A Baker; Qing Geng; Jacqueline Romero; Maria M Picken; Richard L Gamelli; Matthias Majetschak
Journal:  Biochem Biophys Res Commun       Date:  2010-09-26       Impact factor: 3.575

2.  Age and the allocation of organs for transplantation: a case study.

Authors:  Chris Hackler; D Micah Hester
Journal:  Health Care Anal       Date:  2005-06

Review 3.  Disparities in heart and lung transplantation.

Authors:  Wayne Tsuang; Rola Khedraki; Eileen Hsich
Journal:  Curr Opin Organ Transplant       Date:  2021-10-01       Impact factor: 2.269

4.  Ten-year experience with extended criteria cardiac transplantation.

Authors:  Marc D Samsky; Chetan B Patel; Ashleigh Owen; Phillip J Schulte; Jacob Jentzer; Paul B Rosenberg; G Michael Felker; Carmelo A Milano; Adrian F Hernandez; Joseph G Rogers
Journal:  Circ Heart Fail       Date:  2013-10-02       Impact factor: 8.790

Review 5.  Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering.

Authors:  Zhiqiang Liu; Jin Zhou; Haibin Wang; Mengge Zhao; Changyong Wang
Journal:  Regen Med Res       Date:  2013-11-08

6.  [Evaluation of the potential organ donor with special regards to heart donation].

Authors:  Daniel Höfer; Arezu Aliabadi; Christian Ebner; Christoph Hörmann; Stephane Mahr; Regina Mascherbauer; Gerhard Pölzl; Albert Reiter; Andrä Wasler; Thomas Weber; Michael Zink; Andreas Zuckermann; Herwig Antretter
Journal:  Wien Klin Wochenschr       Date:  2010-07-16       Impact factor: 1.704

7.  Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device?

Authors:  Federico Migliore; Giacomo Cavalli; Tomaso Bottio; Pietro De Franceschi; Emanuele Bertaglia; Gino Gerosa; Sabino Iliceto
Journal:  ESC Heart Fail       Date:  2018-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.